首页/数据集/Additional file 3 of Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair

Additional file 3 of Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair

Figshare2025-12-14 更新2026-04-28 收录

胆囊癌耐药机制

靶向治疗联合方案

数据链接：

https://figshare.com/articles/dataset/Additional_file_3_of_Targeting_E2F8_sensitizes_gemcitabine-resistant_gallbladder_cancer_to_PARP_inhibitors_by_disrupting_RRM2-driven_DNA_repair/31103029 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Material 3.

应用场景：

创建时间：

2025-12-14

化疗耐药机制

靶向治疗联合方案

Target therapy is a fundamental treatment for colorectal cancer (CRC), while drug resistance dramatically limited the clinical application. Combination of MEKi and PI3K/mTORi was a promising strategy

DataCite Commons2022-02-21 更新130

Gene expression changes during development of sunitinib resistance in renal cell carcinoma patient derived xenografts. Gene expression changes during development of sunitinib resistance in renal cell carcinoma patient derived xenografts

肾细胞癌耐药机制

靶向治疗联合方案

Transcriptome analysis was used to identify gene expression changes during development of sunitinib resistance in a renal cell carcinoma patient-derived xenograft (PDX) model. During the response phas

NIAID Data Ecosystem40

Table 1_GRHL2-HER3 and E-cadherin mediate EGFR-bypass drug resistance in lung cancer cells.xlsx

肿瘤耐药机制

靶向治疗联合方案

Epidermal growth factor receptor (EGFR) is a major oncogenic protein, and thus EGFR-targeting therapies are widely used in patients with various types of cancer, including lung cancer. However, resist

NIAID Data Ecosystem20

RB-N phosphorylation promotes BRD4-mediated CREB signaling hyperactivation and BET inhibitor resistance

耐药性前列腺癌

靶向治疗联合方案

The combination of CREB inhibitor and JQ1 could overcome the resistance to BET inhibitors in RB loss prostate cancer. Our study firstly showed that GNB1L-CREB pathway was activated after RB loss and c

NIAID Data Ecosystem50

Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML [Bisulfite-Seq]

白血病发病机制

靶向治疗联合方案

Mouse models of chronic myeloid malignancies suggest that targeting mature cells of the malignant clone disrupts feedback loops that promote disease expansion. Here, we show that, in chronic myelomono

NIAID Data Ecosystem40

Additional file 3 of Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair

资源简介：

相关数据集